NRI.TO - Nuvo Pharmaceuticals Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue20,16315,37111,273
Cost of Revenue8,4697,3984,780
Gross Profit11,6947,9746,493
Operating Expenses
Research Development1,0577,4366,951
Selling General and Administrative4,9796,69111,205
Non Recurring---
Total Operating Expenses---
Operating Income or Loss5,658-6,154-11,663
Income from Continuing Operations
Total Other Income/Expenses Net-1331,06245,613
Earnings Before Interest and Taxes5,525-5,09233,950
Interest Expense-29616
Income Before Tax5,525-5,12133,334
Income Tax Expense-516
Minority Interest---
Net Income From Continuing Ops5,525-5,12633,318
Non-recurring Events
Discontinued Operations-2,371-2,371-2,371
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,153-5,12633,318
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares3,153-5,12633,318